Plain-English translation of NCT07041073 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new treatment called EEG-based neurofeedback as an add-on to your regular antidepressant medications. The treatment uses special sensors placed on your scalp to measure your brain's electrical activity in real time, then gives you visual feedback (like a game) to help train your brain to regulate emotions better. The goal is to see if this brain-training approach can reduce depression symptoms in people whose symptoms haven't fully improved with medication alone.
Many people with depression continue to struggle even when taking antidepressants, and doctors need new options to help them feel better. This trial is testing whether training your brain to work differently—using real-time feedback about your own brain activity—might be a safe and effective way to improve mood and emotional control.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll come in twice a week for 5 weeks (10 sessions total). At each session, researchers will place 24 small sensors on your scalp to measure your brain activity. You'll then do a brain-training exercise using a computer game or visual interface that responds to your brain patterns in real time—the game adjusts based on your brain activity to help reinforce healthy emotion regulation. Each session takes about an hour. You'll continue taking your regular antidepressant medications throughout the entire study.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
Spain